Concepedia

Publication | Closed Access

Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study

DOI

151

Citations

9

References

2015

Year

Walter Reinisch, Julián Panés, Sunil Khurana, Gábor Tóth, Fei Hua, Gail M. Comer, Michelle Hinz, Karen Page, Margot O’Toole, Tara McDonnell Moorehead,
Gut

Abstract

ClinicalTrials.gov number NCT01284062.

References

YearCitations

Page 1